Exact Mass: 300.9714
Exact Mass Matches: 300.9714
Found 93 metabolites which its exact mass value is equals to given mass value 300.9714
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
2-amino-6-chloro-4-(3-sulfoanilino)-1,3,5-triazine
2-amino-6-chloro-4-(3-sulfoanilino)-1,3,5-triazine
ELTENAC
ELTENAC
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
1-(4-bromophenyl)-1,4-dihydro-3(2H)-isoquinolinone
1-(4-bromophenyl)-1,4-dihydro-3(2H)-isoquinolinone
Cisplatin; cis-Diamminedichloroplatinum(II); [PtCl2(NH3)2]; CDDP
Cisplatin; cis-Diamminedichloroplatinum(II); [PtCl2(NH3)2]; CDDP
(-)-3S-8-bromo-6-hydroxy-7-methoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid
(-)-3S-8-bromo-6-hydroxy-7-methoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid
ethyl 2-(2,1,3-benzothiadiazol-4-ylsulfonylamino)acetate
ethyl 2-(2,1,3-benzothiadiazol-4-ylsulfonylamino)acetate
2-tert-Butylamino-1-(3,4,5-trichloro-2-thienyl)ethanol
2-tert-Butylamino-1-(3,4,5-trichloro-2-thienyl)ethanol
2-Amino-3-(1H-imidazol-4-yl)-1-propanol dihydrobromide
2-Amino-3-(1H-imidazol-4-yl)-1-propanol dihydrobromide
(1-(5-Bromo-3-nitropyridin-2-yl)pyrrolidin-3-yl)methanol
(1-(5-Bromo-3-nitropyridin-2-yl)pyrrolidin-3-yl)methanol
3-Bromo-1-(3-chloro-2-pyridinyl)-1H-pyrazole-5-carboxylic acid
3-Bromo-1-(3-chloro-2-pyridinyl)-1H-pyrazole-5-carboxylic acid
METHYL 3-AMINO-4-[(2-FURYLMETHYL)SULFONYL]THIOPHENE-2-CARBOXYLATE
METHYL 3-AMINO-4-[(2-FURYLMETHYL)SULFONYL]THIOPHENE-2-CARBOXYLATE
1h-indole-2-carboxylic acid, 3-bromo-5-chloro-, ethyl ester
1h-indole-2-carboxylic acid, 3-bromo-5-chloro-, ethyl ester
4-Chloro-6-nitro-8-(trifluoromethyl)-3-quinolinecarbonitrile
4-Chloro-6-nitro-8-(trifluoromethyl)-3-quinolinecarbonitrile
5-BROMO-3,3-(ETHYLENEDITHIO)-1,3-DIHYDRO-INDOLE-2-ONE
5-BROMO-3,3-(ETHYLENEDITHIO)-1,3-DIHYDRO-INDOLE-2-ONE
4-Chloro-5-(2,4-dichlorobenzyl)-6-methyl-2-pyrimidinamine
4-Chloro-5-(2,4-dichlorobenzyl)-6-methyl-2-pyrimidinamine
5-(3,4-DICHLOROBENZYL)-4-PROPYL-1,2,4-TRIAZOLE-3-THIOL
5-(3,4-DICHLOROBENZYL)-4-PROPYL-1,2,4-TRIAZOLE-3-THIOL
1-(4-Iodo-1H-pyrrolo[2,3-b]pyridin-3-yl)-N,N-dimethylmethanamine
1-(4-Iodo-1H-pyrrolo[2,3-b]pyridin-3-yl)-N,N-dimethylmethanamine
3,4-Dichloro-N-(2,6-dioxotetrahydro-2H-pyran-3-yl)benzamide
3,4-Dichloro-N-(2,6-dioxotetrahydro-2H-pyran-3-yl)benzamide
6-Chloro-2-(4-chlorophenyl)imidazo[1,2-α]pyridine-3-acetonitrile
6-Chloro-2-(4-chlorophenyl)imidazo[1,2-α]pyridine-3-acetonitrile
Phosphoramidochloridicacid, phenyl-, 4-chlorophenyl ester (9CI)
Phosphoramidochloridicacid, phenyl-, 4-chlorophenyl ester (9CI)
4-bromo-9-phenyl-8-oxa-10-azabicyclo[4.4.0]deca-2,4,9,11-tetraen-7-one
4-bromo-9-phenyl-8-oxa-10-azabicyclo[4.4.0]deca-2,4,9,11-tetraen-7-one
Benzenesulfonyl chloride, 4-[(3,5-dimethyl-4-isoxazolyl)methoxy]
Benzenesulfonyl chloride, 4-[(3,5-dimethyl-4-isoxazolyl)methoxy]
4-acetamido-2-(trifluoromethyl)benzenesulfonyl chloride
4-acetamido-2-(trifluoromethyl)benzenesulfonyl chloride
ethyl 2-(2,3-dichlorophenyl)-1,3-thiazole-4-carboxylate
ethyl 2-(2,3-dichlorophenyl)-1,3-thiazole-4-carboxylate
(4-Bromophenyl)(2-thioxo-3-thiazolidinyl)methanone
(4-Bromophenyl)(2-thioxo-3-thiazolidinyl)methanone
Ethyl 6,7-dichloro-3-hydroxy-2-oxo-1,2-dihydroquinoline-4-carboxylate
Ethyl 6,7-dichloro-3-hydroxy-2-oxo-1,2-dihydroquinoline-4-carboxylate
ethyl 5-(5-bromothiophen-2-yl)-1,2-oxazole-3-carboxylate
ethyl 5-(5-bromothiophen-2-yl)-1,2-oxazole-3-carboxylate
Ethyl 2-(2,4-dichlorophenyl)thiazole-4-carboxylate
Ethyl 2-(2,4-dichlorophenyl)thiazole-4-carboxylate
ethyl 2-bromo-6-formyl-4H-thieno[3,2-b]pyrrole-5-carboxylate
ethyl 2-bromo-6-formyl-4H-thieno[3,2-b]pyrrole-5-carboxylate
3-(2-carboxyethyl)-4,6-dichloro-1H-indole-2-carboxylic acid
3-(2-carboxyethyl)-4,6-dichloro-1H-indole-2-carboxylic acid
MDL-29951 is a novel glycine antagonist of NMDA receptor activation, with Ki of 0.14 μM for [3H]glycine binding in vitro and in vivo.
2-[2,3-Dichloro-4-(2-methylidenebutanoyl)phenoxy]acetate
2-[2,3-Dichloro-4-(2-methylidenebutanoyl)phenoxy]acetate
(E)-N-(Benzimidazol-1-yl)-1-(6-chloroimidazo[2,1-b][1,3]thiazol-5-yl)methanimine
(E)-N-(Benzimidazol-1-yl)-1-(6-chloroimidazo[2,1-b][1,3]thiazol-5-yl)methanimine
(3s)-8-bromo-6-hydroxy-7-methoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid
(3s)-8-bromo-6-hydroxy-7-methoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid
8-bromo-6-hydroxy-7-methoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid
8-bromo-6-hydroxy-7-methoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid